These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 2554933)

  • 1. In vitro pharmacological properties of a series of isoprenaline derivatives.
    Eigenmann R; Burkard WP; Holck M; Märki HP; Osterrieder W; Goodman M; Melmon KL
    Arzneimittelforschung; 1989 Aug; 39(8):842-7. PubMed ID: 2554933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological properties of an extremely selective beta 1-adrenoceptor antagonist, 2-[4-[3-(tert-Butylamino)-2-hydroxypropoxy] phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone [+/-)HX-CH 44 BS).
    Daemmgen JW; Engelhardt G; Pelzer H
    Arzneimittelforschung; 1985; 35(1A):383-90. PubMed ID: 2859033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of R(+) and S(-) isomers of befunolol, a partial agonist with high and low affinity sites of beta-adrenoceptors in guinea-pig taenia caecum.
    Takayanagi I; Koike K; Ogishima M
    Arch Int Pharmacodyn Ther; 1989; 300():76-84. PubMed ID: 2575890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
    Hattori Y; Sakuma I; Nakao Y; Kanno M
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles.
    Ogawa T; Ohhara H; Tsunoda H; Kuroki J; Shoji T
    Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological properties of the positive inotropic and alpha 1-adrenoceptor blocking agent saterinone.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Sep; 38(9):1287-92. PubMed ID: 2906245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha and beta adrenergic effects of the stereoisomers of dobutamine.
    Ruffolo RR; Spradlin TA; Pollock GD; Waddell JE; Murphy PJ
    J Pharmacol Exp Ther; 1981 Nov; 219(2):447-52. PubMed ID: 6270308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantiomers of dobutamine increase the force of contraction via beta adrenoceptors, but antagonize competitively the positive inotropic effect mediated by alpha-1 adrenoceptors in the rabbit ventricular myocardium.
    Ishihata A; Kushida H; Endoh M
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1080-7. PubMed ID: 2843626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Arrhythmogenic Actions of (-)-Isoprenaline, Dobutamine and the selective beta 1-adrenoceptor agonist, (+/-)-(1-[3',4'-dihydroxyphenoxy] -2-hydroxy-[3",4"-dimethoxy phenethylamino]-propane)-oxalate (Ro 363).
    Maccarrone C; Malta E; Raper C
    Arzneimittelforschung; 1985; 35(3):592-8. PubMed ID: 2859864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
    Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Muramatsu I; Nagatomo T
    J Pharm Pharmacol; 2005 Jan; 57(1):75-81. PubMed ID: 15638996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro quantitative analysis of the alpha adrenoceptor partial agonist activity of dobutamine and its relevance to inotropic selectivity.
    Kenakin TP
    J Pharmacol Exp Ther; 1981 Feb; 216(2):210-9. PubMed ID: 6109772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugates of catecholamines. IV. In vitro and in vivo pharmacological activity of monodisperse oligopeptide conjugates.
    Rosenkranz RP; Jacobson KA; Verlander MS; Klevans L; O'Donnell M; Goodman M; Melmon KL
    J Pharmacol Exp Ther; 1983 Nov; 227(2):267-73. PubMed ID: 6138424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of tight binding of isoprenaline and terbutaline to beta-adrenoceptors in lung membranes.
    Nerme V; Abrahamsson T; Vauquelin G
    Arch Int Pharmacodyn Ther; 1989; 301():51-65. PubMed ID: 2560366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the properties of prenalterol and corwin at beta 1- and beta 2-adrenoreceptors in vitro.
    Gurden JM; Apperley GH; Drew GM
    J Auton Pharmacol; 1989 Apr; 9(2):79-91. PubMed ID: 2565903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of stereoselectivity in the inotropic and phosphodiesterase inhibitory effects of saterinone enantiomers.
    Armah BI; Muster D; Raap A; Brückner R; Graziadei I
    Arzneimittelforschung; 1989 Nov; 39(11):1384-92. PubMed ID: 2559738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.
    Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G
    Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.